In the largest sample studied to date, we measured cognitive functioning in children and adolescents with pediatric multiple sclerosis (n = 187) as well as those with clinically isolated syndrome (n = 44). Participants were consecutively enrolled from six United States Pediatric Multiple Sclerosis Centers of Excellence. Participants had a mean of 14.8 ± 2.6 years of age and an average disease duration of 1.9 ± 2.2 years. A total of 65 (35%) children with multiple sclerosis and 8 (18%) with clinically isolated syndrome met criteria for cognitive impairment. The most frequent areas involved were fine motor coordination (54%), visuomotor integration (50%), and speeded information processing (35%). A diagnosis of multiple sclerosis (odds ratio = 3.60, confidence interval = 1.07, 12.36, P = .04) and overall neurologic disability (odds ratio = 1.47, confidence interval = 1.10, 2.10, P = .03) were the only independent predictors of cognitive impairment. Cognitive impairment may occur early in these patients, and prompt recognition is critical for their care.
DuquettePMurrayTJPleinesJ. Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr. 1987;111:359–363.
2.
GhezziADeplanoVFaroniJ. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler. 1997;3:43–46.
3.
ChitnisTGlanzBJaffinSHealyB. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler. 2009;15:627–631.
4.
MacAllisterWSBelmanALMilazzoM. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology. 2005;64:1422–1425.
5.
AmatoMPGorettiBGhezziA. Cognitive and psychosocial features of childhood and juvenile MS. Neurology. 2008;70:1891–1897.
6.
BanwellBLAndersonPE. The cognitive burden of multiple sclerosis in children. Neurology. 2005;64:891–894.
7.
TillCGhassemiRAubert-BrocheB. MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. Neuropsychology. 2011;25:319–332.
8.
SmerbeckAMParrishJSerafinD. Visual-cognitive processing deficits in pediatric multiple sclerosis. Mult Scler. 2011;17:449–456.
9.
AmatoMPGorettiBGhezziA. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology. 2010;75:1134–1140.
10.
KruppLBBanwellBTenembaumS. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16 suppl 2):S7–S12.
11.
The Psychological Corporation. The Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: Harcourt Assessment; 1999.
12.
Wechsler Individual Achievement Test: Second Edition. San Antonio, TX: Harcourt Assessment; 2005.
AndersonPAndersonVNorthamETaylorHG. Standardization of the Contingency Naming Test: A measure of reactive flexibility. Clin Neuropsychol Assess. 2000;1:247–273.
15.
DelisDCKaplanEKramerJHOberBA. Delis-Kaplan Executive Function Scale (D-KEFS). San Antonio, TX: Psychological Corporation; 2001.
16.
DelisDKramerJKaplanEOberB. California Verbal Learning Test Manual: Second Edition, Adult Version. San Antonio, TX: Psychological Corporation; 2000.
17.
DelisJHKramerJHKaplanEOberB. California Verbal Learning Test—Children's Version. San Antonio, TX: Psychological Corporation; 1994.
18.
BeeryKEBeeryNA. The Beery-Buktenica Developmental Test of Visual-Motor Integration—5th Edition. Minneapolis, MN: NCS Pearson; 2006.
19.
MatthewsCGKloveH. Instruction Manual for the Adult Neuropsychological Test Battery. Madison, WI: University of Wisconsin Medical School; 1964.
20.
TrittschuhEHCranePKLarsonEB. Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. J Alzheimers Dis. 2011;25:163–173.
LezakMHowiesonDBLoringDWHannayHJFischerJS. Neuropsychological Assessment. New York, NY: Oxford University Press; 2004.
23.
RaoS. Neurobehavioral Aspects of Multiple Sclerosis. New York, NY: Oxford University Press; 1990.
24.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452.
25.
AmatoMPZipoliVPortaccioE. Cognitive changes in multiple sclerosis. Expert Rev Neurother. 2008;8:1585–1596.
26.
MacAllisterWSChristodoulouCMilazzoMKruppLB. Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Dev Neuropsychol. 2007;32:625–644.
27.
AmatoMPPortaccioEGorettiB. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler. 2010;16:1474–1482.
28.
RossKASchwebelDCRinkerJ2ndNessJAckersonJ. Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis. Neurology. 2010;75:2097–2102.
29.
MacAllisterWSBoydJRHollansNJMilazzoMCKruppLB. The psychosocial consequences of pediatric multiple sclerosis. Neurology. 2007;68(16 suppl 2):S66–S69.
30.
GorettiBPortaccioEGhezziA. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. Mult Scler. 2012;18:329–334.
31.
FuentesACollinsDLGarcia-LorenzoD. Memory performance and normalized regional brain volumes in patients with pediatric-onset multiple sclerosis. J Int Neuropsychol Soc. 2012;18:471–480.
32.
TillCDeottoATipuV. White matter integrity and math performance in pediatric multiple sclerosis: a diffusion tensor imaging study. Neuroreport. 2011;22:1005–1009.
